Cotinga Pharmaceuticals Companies
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company’s lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene.COTQF Cotinga Pharmaceuticals Inc. - Seeking Alphaseekingalpha.com/symbol/COTQF
Technology:
Companies
Industry:
AI R&D Pharma (DPI)
Headquarters:
Boston, Suffolk County, Massachusetts, United States
Founded Date:
1999
Register and Claim Ownership